Clinical Trial Update: Irbesartan and Atenolol in Hypertensive Heart Disease [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating irbesartan and atenolol in hypertensive heart disease has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Hypertensive Heart Disease

Drugs mentioned

• AVAPRO (irbesartan)
• TENORMIN (ATENOLOL)

Snippet

Sponsor: Karolinska Institutet | Conditions: Hypertension | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2015-05-05